Here are relevant reports on : class-d-amplifier-market
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Enterprise Asset Management Market by Asset Class (Linear Assets, Production Equipment, Fleet & Mobile Assets, Fixed Assets), Application (Asset Lifecycle Management, Operations, Maintenance, Compliance & Safety, Reporting & Analytics) - Global Forecast to 2030
The global enterprise asset management (EAM) market is projected to grow from USD 5.87 billion in 2025 to USD 9.02 billion by 2030, featuring a CAGR of 9.0%. Some of the enterprise asset management vendors are IBM (US), Oracle (US), SAP (Germany), Hexagon (Sweden), IFS (Sweden), Aptean (US), Trimble (US), ServiceNow (US), Hitachi Energy (Switzerland), and Ramco (India).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Polymer Concrete Market by Class (PMC, PC, PIC), Type (Epoxy, Polyester, Latex), Application (Containments, Pump Bases, Wastewater Containers), End-Use Industries (Infrastructures, Non-Residential Structures), and Region - Global Forecast to 2022
The global polymer concrete market is estimated at USD 448.1 Million in 2017 and is projected to reach USD 641.9 Million by 2022, at a CAGR of 7.5% between 2017 and 2022. The market is witnessing growth due to the growing awareness regarding the use of polymers in concrete due to their high performance and multifunctionality. Increase in spending on repair & maintenance and growth in infrastructural activities in emerging economies are some of the factors driving the market for polymer concrete. Polymer concrete resin providers and polymer concrete fabricators, such as BASF (Germany), Sika (Switzerland), Mapei (Italy), Fosroc (UK), Dow Chemical (US), SAUEREISEN (US), Kwik Bond Polymers (US), Dudick (US), ErgonArmor (US), and Crown Polymers (US) are covered in the report.
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Cancer Supportive Care Drugs Market by Drug Class (G-CSFS, ESAS, Antiemetics, Bisphosphonates, Opioids, Nsaids), Cancer Type (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, Other Cancers) - Global Forecast to 2023
Cancer supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects. With such side effects, there is preference to use supportive care drugs during cancer treatments. Such factors are expected to drive the cancer supportive care drugs market. However, there are some side effects associated with cancer supportive care drugs which may hinder the market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Immunohistochemistry Market by Product & Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) - Global Forecast to 2030
The global immunohistochemistry market, valued at US$3.31 billion in 2024, stood at US$3.55 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$5.14 billion by the end of the period. The increasing number of cancer cases is one of the key factors driving the uptake of IHC products, which, in turn, leads to a greater need for accurate and efficient diagnostic tools such as IHC tests.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Circuit Materials Market by Material Class (Substrate, Conducting Material, Outer Layer), Substrate (Fiberglass Epoxy, Paper-Phenolic), Conducting Material (Copper), Outer Layer (LIPSM, Dry Film Photoimageable), Application, Region - Global Forecast 2023
The circuit materials market size is estimated to be USD 30.58 billion in 2018 and is projected to reach USD 36.85 billion by 2023, at a CAGR of 3.8% between 2018 and 2023. The growth of the circuit materials market can be attributed to their property of high conductivity which is increasing their demand in the electronics sector. Key players operating in the circuit materials market include Shengyi Technology (China), Kingboard Laminates (Hong Kong), ITEQ Corporation (Taiwan), DowDuPont (US), Jinan Guoji Technology (China), Eternal Materials (Taiwan), Rogers Corporation (US), Taiflex Scientific (Taiwan), Isola Group (US), and Nikkan Industries (Japan).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (Anti–Epileptic Drugs,Anti–Arrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Antipsychotic Drugs Market by Therapeutic Class (First Generation, Second Generation, Third Generation), Drug (Aripiprazole, Brexipiprazole, Risperidone), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast to 2027
The global antipsychotic drugs market is projected to reach USD ~25 billion by 2027 from USD 14 billion in 2022, at a CAGR of 8% between 2022 and 2027.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Occupant Classification System (OCS) Market by Vehicle Class (Economy, Mid-size, Luxury), Component Type (ACU, Sensor), Sensor Type (Pressure Sensor, Belt Tension Sensor), Electric Vehicle, Propulsion, and Region - Global Forecast to 2032
The global occupant classification system (OCS) market is projected to reach USD 2.37 billion by 2032 from USD 1.30 billion in 2025 at a CAGR of 9.0% during the forecast period. The major players in the occupant classification system market include Robert Bosch GmbH (Germany), Denso Corporation (Japan), ZF Friedrichshafen AG (Germany), Continental AG (Germany), IEE Smart Sensing Solutions (Luxembourg), AISIN CORPORATION (Japan), and Aptiv (Ireland). These companies offer occupant classification systems for automakers and have strong global distribution networks. Companies are also actively collaborating with global OEMs and launching products to expand their market presence. In January 2024, ZF Friedrichshafen AG (Germany) launched an intelligent seat belt technology to reduce the consequences of accidents.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1, GPE, CGRP), Therapeutic Area (Nephrology, Gastroenterology, Genetic, CNS, Obesity, Diabetes), Formulation (Tablet, Capsule) - Global Forecast to 2030
The global oral proteins and peptides market, valued at US$8.07 billion in 2024, stood at US$9.31 billion in 2025 and is projected to advance at a resilient CAGR of 16.4% from 2025 to 2030, culminating in a forecasted valuation of US$19.93 billion by the end of the period. This growth is driven by several factors, including the rising prevalence of chronic diseases such as diabetes, gastrointestinal disorders, and kidney diseases.
- Published: February 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
